Non-LDL-c parameters in CV risk management and guidelines
Video navigation menu
What is the role of non-LDL-c parameters? 01:02
Lowering of TRL by statins in the TNT trial 03:50
Common link in TG and LDL pathways is similarity in apoB particles 05:51
Increase clearance or reduce production of TRL 07:16
Educational information
This lecture by prof. Kausik Ray, MD was part of an accredited symposium "Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides" held during the virtual ESC Congress 2020.
Faculty
Prof. Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding
Funding for this educational program was provided by an unrestricted educational grant from Amarin.
Online-CME
This is available as accredited online CME for members. Click the button below to enroll:
EnrollThe information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: